Free GLP-1 tool
GLP-1 Plateau Analyzer
See the trend in the weights you enter. The analyzer does not decide that medication should change.
What this result means
Describe whether a series of weekly weights looks like ordinary fluctuation or a relatively flat trend — without diagnosing a plateau or changing treatment.
Requires at least four dated weights spanning three or more weeks, with adjacent measurements at least five days apart. Clustered same-week dates fail closed. The tool computes first-to-last change, percent total-body-weight change, weekly rate, a 3-point rolling average, and the longest elapsed-time streak of interval changes under 0.5% of the first weight per week. A tool-defined relatively flat trend is a transparent educational arithmetic check: the last four dated weights spanning at least 21 days, staying within about 1% of the first weight in that recent window, and under about 0.25%/week. This tool uses a simple educational definition of a relatively flat weight trend. These thresholds are not a medical definition or diagnostic criteria for a weight-loss plateau. The output is trend language plus clinician questions, not a finding that medication stopped working, that a dose is too low, that a dose should increase, that metabolic adaptation is present, that treatment failed, or that a medication should be switched.
What this tool cannot tell you
- That you should increase your medication.
- That your dose is too low or that you should switch drugs.
- That you have metabolic adaptation or another diagnosis.
Methodology & sources
Requires at least four dated weights spanning three or more weeks, with adjacent measurements at least five days apart. Clustered same-week dates fail closed. The tool computes first-to-last change, percent total-body-weight change, weekly rate, a 3-point rolling average, and the longest elapsed-time streak of interval changes under 0.5% of the first weight per week. A tool-defined relatively flat trend is a transparent educational arithmetic check: the last four dated weights spanning at least 21 days, staying within about 1% of the first weight in that recent window, and under about 0.25%/week. This tool uses a simple educational definition of a relatively flat weight trend. These thresholds are not a medical definition or diagnostic criteria for a weight-loss plateau. The output is trend language plus clinician questions, not a finding that medication stopped working, that a dose is too low, that a dose should increase, that metabolic adaptation is present, that treatment failed, or that a medication should be switched.
- Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1)
New England Journal of Medicine · 2021-03-18 · Last verified 2026-09-16
Encoded published week-68 mean percent body-weight change only. Intermediate figure points are not interpolated.
- Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1)
New England Journal of Medicine · 2022-07-21 · Last verified 2026-09-16
Encoded published week-72 mean percent body-weight change for 5 mg, 10 mg, and 15 mg only.
Related WellForm MD resources
Need individualized guidance?
These tools are free public education. WellForm MD also provides physician-led medical weight-loss care when you want a plan that belongs to you.
Book a free consultation